Debut Plus

₹64.01

▼ -2.42 -3.64%

As of 09 Sept 2026 · delayed

NSE Listed

GKB Ophthalmics Ltd. (GKB)

Volume: 17,482Avg Vol 1W: 7,832.2Avg Vol 1M: 2,441.7252W Range:₹60.3₹74
NSE BSE www.gkb.net AI Report
Key Ratios
Checked 8h ago
Market Cap₹33 Cr
Current Price₹64.01
Previous Close₹66.43
High / Low (52w)₹74 / ₹60.3
Volume17,482
Avg Vol (1W)7,832.2
Avg Vol (1M)2,441.72
Stock P/E6.68
Book Value₹104.82
Dividend Yield0%
ROE5.53%
ROA417.6%
Revenue (TTM)₹151 Cr
Revenue Growth—
Profit Margin216.3%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹9.95
P/B0.63
Debt / Equity0.25
50 DMA₹64.76
200 DMA₹64.76
Day change-3.64%
Price Chart
₹64.01▼ 1.52% · 1Y
₹72₹6117K
2026-08-17
2026-09-09

20-day avg volume: 2K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹26 Cr₹26 Cr₹31 Cr₹32 Cr₹30 Cr₹57 Cr₹30 Cr₹33 Cr
EBITDA₹-1 Cr₹-1 Cr₹-3 Cr₹0 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr
Net Profit₹-1 Cr₹-2 Cr₹-4 Cr₹-1 Cr₹2 Cr₹0 Cr₹0 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹110 Cr₹8 Cr₹9 Cr₹6 Cr₹4 Cr₹6 Cr₹151 Cr₹6 Cr
EBITDA₹-5 Cr₹-2 Cr₹-1 Cr₹0 Cr₹2 Cr₹0 Cr₹8 Cr₹0 Cr
Net Profit₹-7 Cr₹-2 Cr₹-2 Cr₹-1 Cr₹1 Cr₹-2 Cr₹1 Cr₹0 Cr
EPS-12.12—————-7.08—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹93 Cr₹102 Cr₹107 Cr₹110 Cr₹112 Cr₹115 Cr₹125 Cr₹132 Cr
Total Liabilities₹39 Cr₹43 Cr₹41 Cr₹43 Cr₹45 Cr₹50 Cr₹69 Cr₹77 Cr
Equity₹55 Cr₹59 Cr₹66 Cr₹67 Cr₹67 Cr₹64 Cr₹56 Cr₹55 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹4 Cr₹3 Cr₹7 Cr₹5 Cr₹-3 Cr₹4 Cr₹-3 Cr₹-3 Cr
Investing₹-10 Cr₹-4 Cr₹-17 Cr₹-4 Cr₹1 Cr₹-2 Cr₹3 Cr₹9 Cr
Financing₹13 Cr₹4 Cr₹3 Cr₹-2 Cr₹-2 Cr₹-2 Cr₹1 Cr₹-6 Cr
Free Cash Flow₹4 Cr₹3 Cr₹7 Cr₹5 Cr₹-3 Cr₹4 Cr₹-3 Cr₹-3 Cr
Shareholding
Promoter 51.15% Institutions 1.79% Public 47.07%
Efficiency & Working Capital
ROCE11.7%
Interest Coverage2.8
Dividend Payout—
Debtor Days110 d
Inventory Days134 d
Payable Days138 d
Cash Conversion Cycle106 d
Working Capital Days244 d
Shareholding Details

As of 2026-06-30

Promoter51.1%
FII1.8%
DII0%
Institutions1.8%
Public47.1%
Promoter Pledge0%
No. of Shareholders2,557
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters50.9%50.9%50.9%50.9%50.9%51%51%51.1%51.1%51.1%51.1%51.1%
FIIs1.8%1.8%1.8%1.8%1.8%1.8%1.8%1.8%1.8%1.8%1.8%1.8%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public47.3%47.3%47.3%47.3%47.3%47.2%47.2%47.2%47.2%47.1%47.1%47.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,1152,2332,3702,6902,5102,5392,5382,5502,6012,6612,6342,557
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Krishna Gopal GuptaShareholding of Promoter and Promoter Group17.9%9,02,812
Vikram GuptaShareholding of Promoter and Promoter Group8.4%4,23,105
Gaurav GuptaShareholding of Promoter and Promoter Group8.1%4,07,966
Veena GuptaShareholding of Promoter and Promoter Group6%3,00,753
Krishnagopal Gupta And SonsShareholding of Promoter and Promoter Group6%3,01,069
Krishna Murari GuptaPublic Shareholding5.5%2,79,293
Tanvi Jignesh MehtaPublic Shareholding4.8%2,43,049
Shefali ChawlaShareholding of Promoter and Promoter Group4.8%2,42,464
Somo Vision Co. Ltd.Public Shareholding4%2,00,000
Brijendra Kumar GuptaPublic Shareholding3.3%1,67,044
Coeus Global Opportunities FundPublic Shareholding1.8%90,000
Lalit Kumar GuptaPublic Shareholding1.4%70,500
Jyotivardhan JaipuriaPublic Shareholding1.3%66,667
Varsha Chugh .Public Shareholding1.3%63,886
Phani Kishore TalluriPublic Shareholding1.3%63,305
Mahendra Girdharilal WadhwaniPublic Shareholding1.2%61,242
Dhwaja Commodity Services Private LimitedPublic Shareholding1%51,503
Dhanpat Mishrimal KothariPublic Shareholding1%51,000
Board of Directors
NameDesignationYear
K G GuptaChairman / Executive Director / M D / Promoter2026
Vikram GuptaNon Executive Director2026
Purushottam MantriIndependent Non Exe. Director2026
Sandhya Ajit KamatIndependent Non Exe. Director2026
Ninad Gurudas KamatIndependent Non Exe. Director2026
Cedric LoboNon Independent Executive Director / WTD2026
Pooja BicholkarCompany Secretary / Compliance Officer2026
Segments — Product
SegmentRevenueShare
Ophthalmics lenses₹0 Cr—
Segments — Geography
RegionRevenueShare
Within India₹16 Cr77.9%
Outside India₹5 Cr22.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10755
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026900142346
202600011011
20262003611
Insider / Designated-Person Trades

9 recent disclosure(s)

Krishna Gopal Gupta & Sons HUFAcquisition · 316
Krishna Gopal Gupta & Sons HUFAcquisition · 343
Krishna Gopal Gupta & Sons HUFAcquisition · 160
Krishna Gopal Gupta & Sons HUFAcquisition · 147
Krishna Gopal Gupta & Sons HUFAcquisition · 50
Krishna Gopal Gupta & Sons HUFAcquisition · 350
Company Information
Incorporated1981
ChairmanK G Gupta
AuditorMSKA & Associates LLP
Investor Email[email protected]
🌐 www.gkb.net ↗

📍 16-A, Tivim Industrial Estate, Mapusa, Goa, 403526

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Gillanders Arbuthnot & Company Ltd.Gillette India Ltd.Ginnifilaments Ltd.Gujarat Industries Power Co Ltd.Giriraj Civil Developers Ltd.Grover Jewells LimitedGK Energy LimitedGujarat Kidney & Super Speciality Ltd.GKW LimitedGland Pharma LimitedGlaxosmithkline Pharmaceuticals Ltd.Glenmark Pharmaceuticals Ltd.All “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search